News Articles Tagged: Lonidamine

Lonidamine's Rebirth: Overcoming Toxicity with Mitochondria-Targeted Delivery

Learn how NINGBO INNO PHARMCHEM CO.,LTD. is overcoming the limitations of lonidamine by developing mitochondria-targeted delivery systems to reduce toxicity and enhance efficacy.

The Power of Precision: How Mitochondria-Targeted Lonidamine is Revolutionizing Cancer Treatment

Discover how Mito-LND, a novel mitochondria-targeted lonidamine derivative, is transforming cancer therapy by enhancing efficacy and reducing toxicity in lung cancer treatment.